Chargement en cours...
Modes of Action of Intravenous Immunoglobulin in Bullous Pemphigoid
Bullous pemphigoid (BP) is an autoantibody-mediated skin blistering disease. Previous studies revealed that intravenous immunoglobulin is therapeutic in animal models of BP by saturating the IgG protective receptor FcRn, thereby accelerating degradation of pathogenic IgG. Sasaoka et al. demonstrate...
Enregistré dans:
| Publié dans: | J Invest Dermatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577376/ https://ncbi.nlm.nih.gov/pubmed/29793619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2018.02.020 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|